Pages that link to "Q70878186"
Jump to navigation
Jump to search
The following pages link to γ‐Aminobutyric Acid Concentration in Cerebrospinal Fluid in Schizophrenia (Q70878186):
Displaying 14 items.
- Molecular substrates of schizophrenia: homeostatic signaling to connectivity (Q30383611) (← links)
- GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes (Q30451228) (← links)
- In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia (Q30873588) (← links)
- Elevated gamma-aminobutyric acid levels in chronic schizophrenia (Q34142882) (← links)
- Clinical relevance of measuring GABA concentrations in cerebrospinal fluid (Q37948429) (← links)
- Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems. (Q39514501) (← links)
- Glutamate, GABA, and CNS disease: A review (Q40091181) (← links)
- GABA and acute psychoses (Q40129402) (← links)
- Schizophrenia: Some Current Neurochemical Approaches (Q40151501) (← links)
- Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid (Q40320448) (← links)
- Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis (Q42243705) (← links)
- CSF GABA is reduced in first-episode psychosis and associates to symptom severity (Q47777392) (← links)
- Plasma GABA levels in psychiatric illness (Q52092504) (← links)
- Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients (Q67470134) (← links)